AHR and infection: Interestingly, although AHR activation increases morbidity and mortality caused by IAV infection, the kinetics of viral growth and the efficacy of the viral clearance, are not significantly different between control and TCDD-treated mice in primary infections nor even during homotypic reinfections (86–89).